3-Methoxypyridine - CAS 7295-76-3
Catalog: |
BB034733 |
Product Name: |
3-Methoxypyridine |
CAS: |
7295-76-3 |
Synonyms: |
3-methoxypyridine |
IUPAC Name: | 3-methoxypyridine |
Description: | 3-Methoxypyridine was used in the study of structure-activity relationships of pyridines as Sir2 histone/protein deacetylase inhibitors. |
Molecular Weight: | 109.13 |
Molecular Formula: | C6H7NO |
Canonical SMILES: | COC1=CN=CC=C1 |
InChI: | InChI=1S/C6H7NO/c1-8-6-3-2-4-7-5-6/h2-5H,1H3 |
InChI Key: | UMJSCPRVCHMLSP-UHFFFAOYSA-N |
Boiling Point: | 65 °C15 mmHg (lit.), 168 °C at 760 mmHg |
Purity: | 95 % |
Density: | 1.083 g/cm3 |
Appearance: | Colorless to yellow liquid |
MDL: | MFCD00673022 |
LogP: | 1.09020 |
GHS Hazard Statement: | H315 (97.62%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112595797-A | Method for determining apixaban intermediate through gas chromatography | 20210105 |
CN-112754981-A | Collagen regeneration promoting preparation and preparation method and application thereof | 20201230 |
CN-111499566-A | Pyridine derivative compound and preparation method thereof | 20200430 |
WO-2021185706-A1 | Ethylene oligomerisation plant for producing alpha-olefins | 20200319 |
WO-2021179274-A1 | ErbB RECEPTOR INHIBITORS AS ANTI-TUMOR AGENTS | 20200313 |
PMID | Publication Date | Title | Journal |
21777010 | 20110825 | Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging | Journal of medicinal chemistry |
20439146 | 20101102 | Development and validation of a specific and sensitive GC-FID method for the determination of impurities in 5-chlorovaleroyl chloride | Journal of pharmaceutical and biomedical analysis |
18947224 | 20081127 | Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease | Journal of medicinal chemistry |
18465765 | 20080101 | Pyridine-catalyzed stereoselective addition of acyclic 1,2-diones to acetylenic esters: synthetic and theoretical studies of an unprecedented rearrangement | Chemistry (Weinheim an der Bergstrasse, Germany) |
17957815 | 20071203 | Reactions of sulphate radicals with substituted pyridines: a structure-reactivity correlation analysis | Chemphyschem : a European journal of chemical physics and physical chemistry |
Complexity: | 65.5 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 109.052763847 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 109.052763847 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 22.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS